Dr. Katakkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6261 NorthLa Cholla Blvd
Tucson, AZ 85718Phone+1 520-261-0690
Education & Training
- Certified by International Academy of Thrombosis/HemostatisBoard Certified, thrombosis and bleeding disorders, 1995 - 1995
- Royal College of PhysiciansFellowship, 1976 - 1976
- W. W. Cross Cancer InstituteFellowship, 1974 - 1975
- General HospitalResidency, 1973 - 1974
- University HospitalResidency, 1971 - 1972
- St Paul HospitalResidency, 1970 - 1971
- St Paul HospitalInternship, 1969 - 1970
- B.J. Medical College - University of PuneClass of 1969
Certifications & Licensure
- AZ State Medical License 1979 - 2026
- WA State Medical License 1979 - 2025
- MD State Medical License 1977 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- ABQAURPCHCQM FABQAURP (2019)
- ABQAURPFABQAURB
- ACPFACP
- Europian Society of Medical Oncologymedical oncology
- International Society Of Thrombosis and HemostasisThrombosis and Hemostasis
- London RCPScD
Publications & Presentations
PubMed
- 22 citationsDanazol in the treatment of myelodysplastic syndromes.Antonio C. Buzaid, Harinder S. Garewal, Scott M. Lippman, Brian G.M. Durie, Suresh B. Katakkar
European Journal of Haematology. 2009-04-24 - 5 citationsUse of Heparin as a Topical Antithrombotic and Anti-inflammatory AgentSuresh B. Katakkar
Journal of the National Cancer Institute. 1993-11-17 - 15 citationsTreatable meningeal involvement in Waldenström's macroglobulinemia.James J. Torrey, Suresh B. Katakkar
Annals of Internal Medicine. 1984-09-01
Journal Articles
- Prolonged Thrombin Time in Asymptomatic Patient with Hypo Dysfibrogememia TucsonSuresh B Katakkar, Journal of Hematalogy and Oncology Research - 4(2):7-8, 8/24/2021
- Chemohormonal Therapy with Combination Nitrogen Mustard and Stilphosterol in Resistant Metastatic Carcinoma of the Prostrate.Katakkar, S.B., American Society of Clinical Oncology Twentieth Annual Meeting, May 6-8, 1984, Toronto, Vol. 3, p. 1
- Phase II Evaluation of Cisplatin, 5FU and Mitomycin in Poorly Differentiated Adenocarcinoma of the Lung.Katakkar, S.B., Fourth World Conference on Lung Cancer
- Join now to see all
Abstracts/Posters
- Combination Chemotherapy in Metastatic Breast Cancer with 5FU, Iphosphamide, Leucovorin and Mitomycin (FILM).Katakkar, S.B., 2ND Milan Breast Cancer Conference, University Veronesi, Milan, Italy
- Fixed Dose Adjuvant Chemotherapy for Breast Cancer.Katakkar, S.B., Garewal, H.S., Kuenzli, S., Third International Conference on Adjuvant Therapy of Breast Cancer, St. Gallen, Switzerland
- Intravenous Lorazepam, Decadron and Low Dose Metoclopramide for the Control of Nausea and Vomiting.Katakkar, S.B., Noyes, D., The American Society of Clinical Oncology, New Orleans, LA
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: